Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Based Tool Measures Cancer Aggressiveness

By LabMedica International staff writers
Posted on 17 Jul 2025

As cancer cases continue to rise globally, early diagnosis and precise treatment have become increasingly challenging. More...

Tumors, which are a leading cause of death, are becoming more complex, making it harder for researchers to predict their aggressiveness and resistance to treatment. The ability to assess how aggressive a tumor is and predict its behavior, including its likelihood to recur, is essential for improving treatment strategies. Now, a new artificial intelligence (AI) tool aims to address this challenge by predicting the aggressiveness of tumors through the identification of specific proteins. This tool, called PROTsi, measures a "stemness index," where a higher score indicates greater aggressiveness and resistance to drugs.

The machine learning model, developed by researchers from the University of São Paulo (São Paulo, Brazi), generates the stemness index based on protein expression data. To develop PROTsi, the researchers relied on datasets from the Clinical Proteomic Tumor Analysis Consortium (CPTAC), which includes data from 11 types of cancer, such as breast, ovarian, lung, kidney, and pancreatic cancers. The tool was designed to predict the aggressiveness of tumors by analyzing proteins linked to tumor progression and their similarity to pluripotent stem cells. As the disease progresses, the stemness index provides insight into how tumor cells are less differentiated, making them more likely to self-renew and become resistant to treatment.

PROTsi was validated across multiple data sets and shown to be effective in distinguishing between different levels of tumor aggressiveness. The research, published in Cell Genomics, confirmed that PROTsi could predict tumor aggressiveness and identify potential targets for new therapies. The tool demonstrated a better performance in differentiating higher-grade tumors, particularly in uterine, pancreatic, and pediatric brain cancers. While the tool works better for some cancers than others, it has the potential to be applied across a wide range of tumors. The researchers plan to continue refining the tool and testing additional computational models to improve predictions and clinical applications.

“We sought to build a model that can be applied to any cancer, but we found that it works better for some than for others. We’re making a data source available for future work,” said Professor Tathiane Malta from the University of São Paulo.

Related Links:
University of São Paulo


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Hemodynamic System Monitor
OptoMonitor
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.